Ideaya aims to raise $263M; Im­muneel ex­tends Se­ries A with $12M

Plus, news about Xy­lo­Cor, Pfiz­er, Evotech, Sky­hawk Ther­a­peu­tics, He­paRe­geniX and Vy­ome:

Ideaya Bio­sciences’ $263M pub­lic of­fer­ing: The South San Fran­cis­co, CA-based biotech

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.